The decrease of NAD(P)H:quinone oxidoreductase 1 activity and increase of ROS production by NADPH oxidases are early biomarkers in doxorubicin cardiotoxicity

Lagoa, RicardoGañán, CarlosLópez-Sánchez, CarmenGarcía-Martínez, VirginioGutierrez-Merino, Carlos2017-01-052017-01-0520141366-5804http://hdl.handle.net/10400.8/2352engCellular bioenergeticsNQO1CardiomyopathyOxidative stressAnthracyclineLipid oxidationResearch Subject Categories::NATURAL SCIENCES::Biology::Cell and molecular biology::ToxicologyResearch Subject Categories::MEDICINE::Physiology and pharmacologyResearch Subject Categories::MEDICINE::Morphology, cell biology, pathologyResearch Subject Categories::MEDICINE::Chemistry::BiochemistryThe decrease of NAD(P)H:quinone oxidoreductase 1 activity and increase of ROS production by NADPH oxidases are early biomarkers in doxorubicin cardiotoxicityjournal article10.3109/1354750X.2014.885084